These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 11235755)

  • 1. Aprotinin and the systemic inflammatory response after cardiopulmonary bypass.
    Mojcik CF; Levy JH
    Ann Thorac Surg; 2001 Feb; 71(2):745-54. PubMed ID: 11235755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of nafamostat mesilate and minimal-dose aprotinin on blood-foreign surface interactions in cardiopulmonary bypass.
    Kaminishi Y; Hiramatsu Y; Watanabe Y; Yoshimura Y; Sakakibara Y
    Ann Thorac Surg; 2004 Feb; 77(2):644-50. PubMed ID: 14759453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion.
    Wachtfogel YT; Kucich U; Hack CE; Gluszko P; Niewiarowski S; Colman RW; Edmunds LH
    J Thorac Cardiovasc Surg; 1993 Jul; 106(1):1-9; discussion 9-10. PubMed ID: 7686593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aprotinin in coronary operation with cardiopulmonary bypass: does "low-dose" aprotinin inhibit the inflammatory response?
    Englberger L; Kipfer B; Berdat PA; Nydegger UE; Carrel TP
    Ann Thorac Surg; 2002 Jun; 73(6):1897-904. PubMed ID: 12078788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of low-dose aprotinin on the inflammatory reaction due to cardiopulmonary bypass in children.
    Seghaye MC; Duchateau J; Grabitz RG; Jablonka K; Wenzl T; Marcus C; Messmer BJ; von Bernuth G
    Ann Thorac Surg; 1996 Apr; 61(4):1205-11. PubMed ID: 8607684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterizing the inflammatory response to cardiopulmonary bypass in children.
    Kozik DJ; Tweddell JS
    Ann Thorac Surg; 2006 Jun; 81(6):S2347-54. PubMed ID: 16731102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aprotinin: antifibrinolytic and anti-inflammatory mechanisms of action in cardiac surgery with cardiopulmonary bypass.
    Donahue MA; Price PM
    Dynamics; 2002; 13(3):16-23. PubMed ID: 12640841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic inflammatory response to coronary artery bypass graft surgery.
    Hess PJ
    Am J Health Syst Pharm; 2005 Sep; 62(18 Suppl 4):S6-9. PubMed ID: 16227195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiopulmonary bypass-induced inflammation: is it important?
    Hill GE
    J Cardiothorac Vasc Anesth; 1998 Apr; 12(2 Suppl 1):21-5. PubMed ID: 9583572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic inflammation and cardiac surgery: an update.
    Asimakopoulos G
    Perfusion; 2001 Sep; 16(5):353-60. PubMed ID: 11565890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of aprotinin in the reduction of inflammatory systemic response in children undergoing surgery with cardiopulmonary bypass.
    Ferreira CA; Vicente WV; Evora PR; Rodrigues AJ; Klamt JG; Carlotti AP; Carmona F; Manso PH
    Rev Bras Cir Cardiovasc; 2010; 25(1):85-98. PubMed ID: 20563473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory response to cardiopulmonary bypass.
    Levy JH; Tanaka KA
    Ann Thorac Surg; 2003 Feb; 75(2):S715-20. PubMed ID: 12607717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does aprotinin influence the inflammatory response to cardiopulmonary bypass in patients?
    Schmartz D; Tabardel Y; Preiser JC; Barvais L; d'Hollander A; Duchateau J; Vincent JL
    J Thorac Cardiovasc Surg; 2003 Jan; 125(1):184-90. PubMed ID: 12539003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review and application of serine protease inhibition in coronary artery bypass graft surgery.
    Engles L
    Am J Health Syst Pharm; 2005 Sep; 62(18 Suppl 4):S9-14. PubMed ID: 16227196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aprotinin in cardiopulmonary bypass--effects on the Hageman factor (FXII)--Kallikrein system and blood loss.
    Fuhrer G; Gallimore MJ; Heller W; Hoffmeister HE
    Blood Coagul Fibrinolysis; 1992 Feb; 3(1):99-104. PubMed ID: 1377956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aprotinin and the protease-activated receptor 1 thrombin receptor: antithrombosis, inflammation, and stroke reduction.
    Day JR; Landis RC; Taylor KM
    Semin Cardiothorac Vasc Anesth; 2006 Jun; 10(2):132-42. PubMed ID: 16959740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies.
    Wan S; LeClerc JL; Vincent JL
    Chest; 1997 Sep; 112(3):676-92. PubMed ID: 9315800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiopulmonary bypass and the inflammatory response: a role for serine protease inhibitors?
    Murkin JM
    J Cardiothorac Vasc Anesth; 1997 Apr; 11(2 Suppl 1):19-23; discussion 24-5. PubMed ID: 9106010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aprotinin. A review of its pharmacology and therapeutic efficacy in reducing blood loss associated with cardiac surgery.
    Davis R; Whittington R
    Drugs; 1995 Jun; 49(6):954-83. PubMed ID: 7543841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase of bradykinin in plasma of patients undergoing cardiopulmonary bypass: the importance of lung exclusion.
    Cugno M; Nussberger J; Biglioli P; Alamanni F; Coppola R; Agostoni A
    Chest; 2001 Dec; 120(6):1776-82. PubMed ID: 11742901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.